66 related articles for article (PubMed ID: 25174499)
21. Liquid chromatography studies on the enzymatic degradation of luteinizing hormone-releasing hormone analogues with off-line identification by mass spectrometry.
Péter A; Devadder S; Laus G; Tourwé D
J Chromatogr A; 1996 Apr; 729(1-2):137-42. PubMed ID: 9004935
[TBL] [Abstract][Full Text] [Related]
22. Increased paracellular absorption by bile salts and P-glycoprotein stimulated efflux of otilonium bromide in Caco-2 cells monolayers as a model of intestinal barrier.
Catalioto RM; Triolo A; Giuliani S; Altamura M; Evangelista S; Maggi CA
J Pharm Sci; 2008 Sep; 97(9):4087-100. PubMed ID: 18200532
[TBL] [Abstract][Full Text] [Related]
23. Development, validation, and application of a novel 7-day Caco-2 cell culture system.
Cai Y; Xu C; Chen P; Hu J; Hu R; Huang M; Bi H
J Pharmacol Toxicol Methods; 2014; 70(2):175-81. PubMed ID: 25034865
[TBL] [Abstract][Full Text] [Related]
24. Caco-2 cells permeability evaluation of nifuroxazide derivatives with potential activity against methicillin-resistant Staphylococcus aureus (MRSA).
B Fernandes M; Gonçalves JE; C Tavares L; Storpirtis S
Drug Dev Ind Pharm; 2015; 41(7):1066-72. PubMed ID: 24918173
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of Glucose Transport by Tomatoside A, a Tomato Seed Steroidal Saponin, through the Suppression of GLUT2 Expression in Caco-2 Cells.
Li B; Terazono Y; Hirasaki N; Tatemichi Y; Kinoshita E; Obata A; Matsui T
J Agric Food Chem; 2018 Feb; 66(6):1428-1434. PubMed ID: 29355315
[TBL] [Abstract][Full Text] [Related]
26. Absorption of poorly water soluble drugs subject to apical efflux using phospholipids as solubilizers in the Caco-2 cell model.
Kapitza SB; Michel BR; van Hoogevest P; Leigh ML; Imanidis G
Eur J Pharm Biopharm; 2007 Apr; 66(1):146-58. PubMed ID: 17071065
[TBL] [Abstract][Full Text] [Related]
27. Transepithelial transport of 6-O-caffeoylsophorose across Caco-2 cell monolayers.
Phuong HL; Qiu J; Kuwahara T; Fukui K; Yoshiyama K; Matsugano K; Terahara N; Matsui T
Food Chem; 2013 May; 138(1):101-6. PubMed ID: 23265462
[TBL] [Abstract][Full Text] [Related]
28. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs.
Dahan A; Amidon GL
Mol Pharm; 2009; 6(1):19-28. PubMed ID: 19248230
[TBL] [Abstract][Full Text] [Related]
29. [Intestional absorption and mechanism of tiliani in Caco-2 cell model].
Huang Z; Xing J; Wang X; Wang S; Yuan Y
Zhongguo Zhong Yao Za Zhi; 2012 May; 37(9):1315-8. PubMed ID: 22803383
[TBL] [Abstract][Full Text] [Related]
30. Effective treatment of experimental human endometrial cancers with targeted cytotoxic luteinizing hormone-releasing hormone analogues AN-152 and AN-207.
Engel JB; Keller G; Schally AV; Nagy A; Chism DD; Halmos G
Fertil Steril; 2005 Apr; 83 Suppl 1():1125-33. PubMed ID: 15831285
[TBL] [Abstract][Full Text] [Related]
31. Effect of structural modification of α-aminoxy peptides on their intestinal absorption and transport mechanism.
Ma B; Zha H; Li N; Yang D; Lin G
Mol Pharm; 2011 Aug; 8(4):1073-82. PubMed ID: 21630669
[TBL] [Abstract][Full Text] [Related]
32. Preparation of icariside II-phospholipid complex and its absorption across Caco-2 cell monolayers.
Jin X; Zhang ZH; Sun E; Tan XB; Zhu FX; Li SL; Jia XB
Pharmazie; 2012 Apr; 67(4):293-8. PubMed ID: 22570934
[TBL] [Abstract][Full Text] [Related]
33. Transport characteristics of rutin deca (H-) sulfonate sodium across Caco-2 cell monolayers.
He Y; Zeng S
J Pharm Pharmacol; 2005 Oct; 57(10):1297-303. PubMed ID: 16259758
[TBL] [Abstract][Full Text] [Related]
34. The impact of P-glycoprotein mediated efflux on absorption of 11 sedating and less-sedating antihistamines using Caco-2 monolayers.
Crowe A; Wright C
Xenobiotica; 2012 Jun; 42(6):538-49. PubMed ID: 22188412
[TBL] [Abstract][Full Text] [Related]
35. Investigation of the route of absorption of lipid and sugar modified leu-enkephalin analogues and their enzymatic stability using the caco-2 cell monolayer system.
Wu S; Campbell C; Koda Y; Blanchfield JT; Toth I
Med Chem; 2006 Mar; 2(2):203-11. PubMed ID: 16787368
[TBL] [Abstract][Full Text] [Related]
36. Permeability, transport, and metabolism of solutes in Caco-2 cell monolayers: a theoretical study.
Sun H; Pang KS
Drug Metab Dispos; 2008 Jan; 36(1):102-23. PubMed ID: 17932224
[TBL] [Abstract][Full Text] [Related]
37. Disposition mechanisms of raloxifene in the human intestinal Caco-2 model.
Jeong EJ; Lin H; Hu M
J Pharmacol Exp Ther; 2004 Jul; 310(1):376-85. PubMed ID: 15020665
[TBL] [Abstract][Full Text] [Related]
38. Sodium-dependent glucose transporter 1 and glucose transporter 2 mediate intestinal transport of quercetrin in Caco-2 cells.
Li S; Liu J; Li Z; Wang L; Gao W; Zhang Z; Guo C
Food Nutr Res; 2020; 64():. PubMed ID: 32612490
[TBL] [Abstract][Full Text] [Related]
39. Trivariate Linear Regression and Machine Learning Prediction of Possible Roles of Efflux Transporters in Estimated Intestinal Permeability Values of 301 Disparate Chemicals.
Shimizu M; Hayasaka R; Kamiya Y; Yamazaki H
Biol Pharm Bull; 2022 Aug; 45(8):1142-1157. PubMed ID: 35644566
[TBL] [Abstract][Full Text] [Related]
40. Intracellular Retention of Three Quinuclidine Derivatives in Caco-2 Permeation Experiments: Mechanisms and Impact on Estimating Permeability and Active Efflux Ratio.
Jin H; Kapadnis S; Chen T; Lee D; McRiner A; Cook A; Burnett DA; Koenig G; Tang C
Drug Metab Lett; 2016; 10(3):161-171. PubMed ID: 27456669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
